New paradigms in cell death in human diabetic nephropathy
New paradigms in cell death in human diabetic nephropathy
7 de septiembre de 2010
Unbiased gene expression profiling identified novel cell death molecules in human diabetic nephropathy. The expression of TNFrelated apoptosis-inducing ligand (TRAIL), its decoy receptor osteoprotegerin, and receptors Fas (a Fas ligand receptor) and CD74 (a migration inhibitory factor (MIF) receptor) were induced in human diabetic nephropathy. Cell culture studies supported the functional relevance of this observation and the relationship to a high glucose environment. To define novel proapoptotic proteins upregulated in diabetic nephropathy, functional genomic screens for novel apoptosis mediators were integrated with genome-wide expression profiling and identified candidates for further functional analysis, including brain acid-soluble protein 1 (BASP1). Several lines of evidence point toward induction of endoplasmic reticulum stress response in human diabetic nephropathy. Functional studies defining an unequivocal contribution of endoplasmic reticulum stress to cell death in this setting are still needed. Further comparative studies will be required to define whether there is a specific aspect of apoptosis in progressive human diabetic nephropathy or whether the mechanisms are shared among all patients with chronic kidney disease. The next challenge will be to define the consequence of therapeutic interference of the apoptosis pathways in diabetic nephropathy and chronic kidney disease.
Ficheros disponibles
Actualidad
Actualidad
Actualidad Quirónsalud: al día contigo
- 17 de marzo de 2026
El Hospital Universitari General de Catalunya (HUGC) destaca en las Jornadas ANDE con tres aportaciones...
Sant Cugat 16 marzo 2026, el Hospital Universitari General de Catalunya ha participado activamente en las 36 Jornadas Nacionales de Enfermeras Gestoras (ANDE), celebradas de...Hospital Universitari General de Catalunyaes/red-centros/hospital-universitari-general-catalunya - 16 de marzo de 2026
La Dra. Marta Cremades, directora médica de la Fundación Jiménez Díaz, reconocida en la XIII edición...
La Dra. Cremades fue incluida en el ranking de referencia en liderazgo femenino de España, que elabora cada año la revista MagasHospital Universitario Fundación Jiménez Díazes/red-centros/hospital-universitario-fundacion-jimenez-diaz - 16 de marzo de 2026
El Hospital Quirónsalud Córdoba y la AECC impulsan su colaboración con proyectos para pacientes de cáncer...
Las iniciativas incluyen un programa de apoyo terapéutico para mujeres mastectomizadas y la dotación de material lúdico y educativo para hacer más llevadera la estancia hospi...Hospital Quirónsalud Córdobaes/red-centros/hospital-quironsalud-cordoba





